Type 2 diabetes splenasthenic syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Type 2 diabetes patients who meet the Western medicine diagnostic criteria for diabetes; 2. Those with spleen deficiency of traditional Chinese medicine; 3. Blood glucose [7.0 mmol/L <=FPG (venous blood) <=10.0mmol/L; 7.0% <HbA 1 c (HbA 1 c) <=9.0%]; 4. Age 30 ~75 years (including both ends), gender limitation; 5. The subject was informed and voluntarily signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients with type 1 diabetes, gestational diabetes, type 2 diabetes and other special types of diabetes that need insulin therapy; 2. Patients complicated with acute complications of diabetes mellitus; 3. Combined with severe heartand cerebrovascular diseases and severe primary diseases such as liver, kidney and hematopoietic system; 4. People with known allergies and allergies to the study drug; 5. Pregnant andlactating pregnant women and women with recent family planning; 6. Patients with long-term alcoholism, drug dependence, and mental illness; 7. Those who have participated in or are attending other drug clinicaltrials within one month before the screening period of the study; 8. The investigator is not inappropriate to attend the clinical investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| fasting blood-glucose ;Blood glucose at 2 hours after the meal; | — |
Secondary
| Measure | Time frame |
|---|---|
| glycosylated hemoglobin;Fasting insulin;Fasting C peptide;And 2-hour postprandial insulin;C peptide; | — |
Countries
China
Contacts
The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine